Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3672942 | 0.84 | KDM4E (0.32) | POLBALDH1A1 | |
| SCHEMBL4310919 | 0.82 | TLR8 (0.38) | POLBALDH1A1EPHX2ALOX5TLR8 | |
| Benzene SCHEMBL28095277 | 0.80 | MEN1 (0.35) | POLBALDH1A1 | |
| SCHEMBL19963527 | 0.75 | TSHR (0.33) | POLBALOX5TLR8 | |
| SCHEMBL13274053 | 0.75 | MEN1 (0.42) | POLBALDH1A1EPHX2ALOX5TLR8 | |
| SCHEMBL3470369 | 0.74 | — | — | |
| SCHEMBL19396012 | 0.73 | NPC1 (0.33) | POLB | |
| SCHEMBL17541776 | 0.72 | ALDH1A1 (0.38) | POLBALDH1A1 | |
| SCHEMBL6421490 | 0.71 | ALDH1A1 (0.48) | POLBALDH1A1EPHX2ALOX5TLR8 | |
| SCHEMBL3183584 | 0.71 | ALDH1A1 (0.46) | POLBALDH1A1EPHX2ALOX5TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170275236-A1 | DIAMINE COMPOUNDS, DINITRO COMPOUNDS AND OTHER COMPOUNDS, AND METHODS OF PRODUCING THEREOF AND USES RELATED THEREOF | MICROMIDAS, INC. (US) | 2017-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170275236-A1 | DIAMINE COMPOUNDS, DINITRO COMPOUNDS AND OTHER COMPOUNDS, AND METHODS OF PRODUCING THEREOF AND USES RELATED THEREOF | DDC, DDT, DAO | POLB 2749/4885ALDH1A1 733/4885EPHX2 1292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.